Spots Global Cancer Trial Database for stage iii squamous cell carcinoma of the hypopharynx

Every month we try and update this database with for stage iii squamous cell carcinoma of the hypopharynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer	NCT00003809	Head and Neck C...	cetuximab cisplatin	18 Years - 120 Years	Eastern Cooperative Oncology Group
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00033449	Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo...	gefitinib radiation thera... cisplatin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Biomarkers in Patients With Head and Neck Cancer	NCT01466257	Head and Neck C...	cetuximab cisplatin DNA analysis gene expression... mutation analys... laboratory biom...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors	NCT00006036	Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	cisplatin lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer	NCT00004917	Anemia Head and Neck C...	epoetin alfa cisplatin radiation thera...	18 Years -	Radiation Therapy Oncology Group
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00281840	Head and Neck C...	bevacizumab docetaxel conventional su... radiation thera...	18 Years -	Case Comprehensive Cancer Center
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck	NCT00084318	Head and Neck C...	cetuximab cisplatin docetaxel radiation thera...	18 Years -	Radiation Therapy Oncology Group
PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery	NCT00276523	Head and Neck C...	PEG-interferon ... Conventional su... Neoadjuvant the...	18 Years -	M.D. Anderson Cancer Center
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx	NCT00002839	Head and Neck C...	cisplatin fluorouracil conventional su... neoadjuvant the... radiation thera...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer	NCT02177838	Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Tongue Cancer	cetuximab cisplatin external beam r... laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer	NCT00002654	Head and Neck C...	chemotherapy cisplatin low-LET cobalt-... low-LET electro... low-LET photon ...	20 Years - 75 Years	Swiss Group for Clinical Cancer Research
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer	NCT00003888	Head and Neck C...	cisplatin docetaxel fluorouracil radiation thera...	18 Years - 70 Years	European Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00006107	Head and Neck C...	Taxotere Surgery radiation thera...	18 Years -	Dana-Farber Cancer Institute
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer	NCT00023959	Metastatic Squa... Recurrent Adeno... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Untreated Metas...	hydroxyurea fluorouracil bevacizumab radiation thera... filgrastim laboratory biom...	18 Years -	National Cancer Institute (NCI)
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx	NCT00757549	Head and Neck C...	cetuximab cisplatin TdT-mediated dU... 3'-deoxy-3'-[18... immunohistochem... laboratory biom... fludeoxyglucose... radiation thera...	18 Years - 120 Years	Mayo Clinic
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer	NCT00482872	Head and Neck C...	gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom...	18 Years - 120 Years	Vanderbilt University Medical Center
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer	NCT00068237	Head and Neck C... Radiation Toxic... Xerostomia	salivary gland ... Post-operative ...	18 Years -	Radiation Therapy Oncology Group
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer	NCT00963326	Head and Neck C...	laboratory biom...	15 Years -	National Cancer Institute (NCI)
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer	NCT00720083	Head and Neck C...	cisplatin vandetanib radiation thera...	18 Years -	Radiation Therapy Oncology Group
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00114153	Head and Neck C...	capecitabine carboplatin conventional su... radiation thera...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer	NCT00005035	Head and Neck C...	oxaliplatin	18 Years -	National Cancer Institute (NCI)
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer	NCT00898664	Head and Neck C...	cytogenetic ana... gene expression... mutation analys... polymerase chai... immunohistochem... laboratory biom...	18 Years -	Vanderbilt-Ingram Cancer Center
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	NCT00352118	Head and Neck C...	filgrastim pegfilgrastim cisplatin docetaxel fluorouracil conventional su... radiation thera...	18 Years -	Masonic Cancer Center, University of Minnesota
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases	NCT00062348	Colorectal Canc... Head and Neck C... Metastatic Canc...	boronophenylala... sodium borocapt... conventional su...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer	NCT00963326	Head and Neck C...	laboratory biom...	15 Years -	National Cancer Institute (NCI)
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx	NCT00004227	Head and Neck C...	cetuximab conventional su... radiation thera...	18 Years -	University of Alabama at Birmingham
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00003328	Head and Neck C...	porfiromycin radiation thera...	18 Years -	National Cancer Institute (NCI)
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue	NCT00002735	Head and Neck C...	Induction chemo... cisplatin fluorouracil low-LET cobalt-...	18 Years - 120 Years	SWOG Cancer Research Network
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	NCT00063895	Recurrent Non-s... Recurrent Ovari... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Non-sm... Stage IV Ovaria... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam...	erlotinib hydro... pharmacological... pharmacogenomic... laboratory biom...	18 Years -	National Cancer Institute (NCI)
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer	NCT00049140	Head and Neck C...	EF5 bioluminescence flow cytometry immunohistochem... biopsy	18 Years -	Duke University
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery	NCT00041171	Adult Solid Tum... Breast Cancer Head and Neck C... Kidney and Urin... Male Reproducti... Thorax and Resp...	Hypericum perfo... docetaxel placebo	18 Years - 120 Years	Alliance for Clinical Trials in Oncology
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00410826	Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo...	erlotinib hydro... cisplatin 3-dimensional c... intensity-modul... quality-of-life...	18 Years -	University of Washington
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer	NCT00415298	Head and Neck C...	DACH polymer pl... oxaliplatin gene expression... immunohistochem... pharmacological... biopsy	18 Years -	National Cancer Institute (NCI)
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	NCT00089362	Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas...	alvespimycin hy... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer	NCT00897793	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer	venipuncture radiation thera...	18 Years -	Vanderbilt-Ingram Cancer Center
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	NCT00721513	Head and Neck C...	cetuximab cisplatin docetaxel fluorouracil computed tomogr... positron emissi... quality-of-life... 3-dimensional c... intensity-modul...	18 Years - 120 Years	Wake Forest University Health Sciences
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer	NCT00851877	Head and Neck C...	Cetuximab Cisplatin Nab-Paclitaxel intensity-modul...	18 Years - 120 Years	University of Texas Southwestern Medical Center
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer	NCT00049140	Head and Neck C...	EF5 bioluminescence flow cytometry immunohistochem... biopsy	18 Years -	Duke University
Docetaxel in Treating Patients With Solid Tumors	NCT00003565	Bladder Cancer Breast Cancer Head and Neck C... Lung Cancer Unspecified Adu...	docetaxel	18 Years -	Alliance for Clinical Trials in Oncology
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer	NCT00003251	Drug/Agent Toxi... Head and Neck C... Radiation Toxic...	amifostine trih... cisplatin paclitaxel radiation thera...	18 Years -	National Cancer Institute (NCI)
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck	NCT00079053	Head and Neck C...	erlotinib hydro... adjuvant therap...	18 Years - 120 Years	Canadian Cancer Trials Group
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery	NCT00738868	Head and Neck C...	cetuximab stereotactic bo...	18 Years -	National Cancer Institute (NCI)
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy	NCT01728480	Mucositis Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer	entolimod intensity-modul... cisplatin pharmacological... laboratory biom...	18 Years -	Roswell Park Cancer Institute
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer	NCT02177838	Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Tongue Cancer	cetuximab cisplatin external beam r... laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer	NCT00084435	Head and Neck C...	cisplatin docetaxel radiation thera...	18 Years -	SWOG Cancer Research Network
Radiation Therapy in Treating Patients With Head and Neck Cancer	NCT00021125	Head and Neck C... Non-melanomatou...	adjuvant therap... radiation thera...	-	National Cancer Institute (NCI)
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy	NCT00898430	Head and Neck C...	DNA Microarray ... MALDI-TOF mass ... DNA microarray ...	-	Vanderbilt-Ingram Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck	NCT00720304	Head and Neck C...	docetaxel erlotinib hydro... fluorescence in... polymerase chai... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... therapeutic con... intensity-modul... radiation thera...	18 Years -	Case Comprehensive Cancer Center
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer	NCT00899821	Head and Neck C...	aldesleukin recombinant int... sargramostim immunologic tec... biopsy	20 Years - 80 Years	NYU Langone Health
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx	NCT00002839	Head and Neck C...	cisplatin fluorouracil conventional su... neoadjuvant the... radiation thera...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer	NCT00006033	Head and Neck C...	gene therapy interleukin-2 g... methotrexate	18 Years -	National Cancer Institute (NCI)
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer	NCT00003582	Carcinoma of Un... Head and Neck C...	amifostine trih... cisplatin fluorouracil paclitaxel quality-of-life... radiation thera...	18 Years - 120 Years	University of Miami
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx	NCT00498953	Head and Neck C...	carboplatin cisplatin docetaxel fluorouracil lapatinib ditos... cytogenetic ana... fluorescence in... in situ hybridi... polymerase chai... reverse transcr... immunohistochem... laboratory biom... conventional su... neoadjuvant the... fludeoxyglucose... radiation thera...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery	NCT00738868	Head and Neck C...	cetuximab stereotactic bo...	18 Years -	National Cancer Institute (NCI)
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx	NCT00004234	Head and Neck C... Oral Complicati...	management of t... radiation thera...	16 Years - 120 Years	Canadian Cancer Trials Group
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer	NCT01313390	Head and Neck C...	docetaxel everolimus laboratory biom... pharmacological...	18 Years -	University College, London
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx	NCT00004234	Head and Neck C... Oral Complicati...	management of t... radiation thera...	16 Years - 120 Years	Canadian Cancer Trials Group
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer	NCT00281840	Head and Neck C...	bevacizumab docetaxel conventional su... radiation thera...	18 Years -	Case Comprehensive Cancer Center
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck	NCT00083057	Head and Neck C...	gefitinib paclitaxel radiation thera...	18 Years -	National Institutes of Health Clinical Center (CC)
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.	NCT01469429	Metastatic Squa... Salivary Gland ... Stage 0 Hypopha... Stage 0 Larynge... Stage 0 Lip and... Stage 0 Nasopha... Stage 0 Orophar... Stage 0 Paranas... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage II Saliva... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Verruc... Stage II Verruc... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Squamo... Stage IV Squamo... Stage IVA Saliv... Stage IVA Squam... Stage IVA Oral ... Stage IVA Squam... Stage IVA Nasal... Stage IVA Verru... Stage IVA Verru... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Oral ... Stage IVB Verru... Stage IVB Verru... Stage IVC Saliv... Stage IVC Squam... Stage IVC Oral ... Stage IVC Squam... Paranasal Sinus... Stage IVC Verru... Stage IVC Verru... Tongue Cancer	placebo laboratory biom... questionnaire a... chemoprevention chemoprevention placebo	21 Years -	Ohio State University Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	NCT00049283	Metastatic Squa... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer Untreated Metas...	erlotinib hydro... docetaxel radiation thera... therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat	NCT00017173	Head and Neck C...	Ad5CMV-p53 gene cisplatin conventional su... radiation thera...	18 Years -	SWOG Cancer Research Network
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia	NCT00081029	Head and Neck C... Radiation Toxic... Xerostomia	management of t... radiation thera...	-	National Cancer Institute (NCI)
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer	NCT00482872	Head and Neck C...	gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom...	18 Years - 120 Years	Vanderbilt University Medical Center
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract	NCT00765440	Head and Neck C... Infection Malnutrition	therapeutic nut... placebo	18 Years - 75 Years	Centre Antoine Lacassagne
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors	NCT00006036	Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	cisplatin lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	NCT00721513	Head and Neck C...	cetuximab cisplatin docetaxel fluorouracil computed tomogr... positron emissi... quality-of-life... 3-dimensional c... intensity-modul...	18 Years - 120 Years	Wake Forest University Health Sciences
Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery	NCT00002670	Head and Neck C...	chemotherapy cisplatin low-LET cobalt-... low-LET electro... low-LET photon ...	18 Years -	Radiation Therapy Oncology Group
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer	NCT00566540	Head and Neck C...	Cisplatin Paclitaxel Intensity-Modul... Triple endoscop...	18 Years -	Ohio State University Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	NCT00049283	Metastatic Squa... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Squamo... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer Untreated Metas...	erlotinib hydro... docetaxel radiation thera... therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer	NCT01155609	Mucositis Oral Complicati... Oral Complicati... Recurrent Adeno... Recurrent Basal... Recurrent Lymph... Recurrent Lymph... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Lymphoe... Stage I Lymphoe... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage II Adenoi... Stage II Basal ... Stage II Lympho... Stage II Lympho... Stage II Mucoep... Stage II Saliva... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Verruc... Stage II Verruc... Stage III Adeno... Stage III Basal... Stage III Lymph... Stage III Lymph... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Lympho... Stage IV Lympho... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	quality-of-life... management of t... L-lysine	18 Years -	University of Washington
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer	NCT00002476	Head and Neck C...	bleomycin sulfa... fluorouracil leucovorin calc... methotrexate vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera...	18 Years -	National Cancer Institute (NCI)
Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy	NCT01210872	Head and Neck C...	questionnaire a... quality-of-life... standard follow...	18 Years - 70 Years	National Cancer Institute (NCI)
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck	NCT00906360	Metastatic Squa... Recurrent Metas... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Untreated Metas...	sunitinib malat... pharmacological... 3-dimensional c... cetuximab	18 Years -	National Cancer Institute (NCI)
Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck	NCT00081211	Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Salivary Gland ... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo...	PV701	18 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck	NCT00003200	Head and Neck C...	Taxotere Radiation thera...	18 Years -	Dana-Farber Cancer Institute
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy	NCT00559156	Head and Neck C...	arginine/omega-... cisplatin adjuvant therap... radiation thera...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: